Chemical Component Summary | |
---|---|
Name | 1-hydrazinophthalazine |
Synonyms | Hydralazine; phthalazin-1-ylhydrazine |
Identifiers | phthalazin-1-ylhydrazine |
Formula | C8 H8 N4 |
Molecular Weight | 160.18 |
Type | NON-POLYMER |
Isomeric SMILES | c1ccc2c(c1)cnnc2NN |
InChI | InChI=1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12) |
InChIKey | RPTUSVTUFVMDQK-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 20 |
Chiral Atom Count | 0 |
Bond Count | 21 |
Aromatic Bond Count | 11 |
Drug Info: DrugBank
DrugBank ID | DB01275 |
---|---|
Name | Hydralazine |
Groups | approved |
Description | Originally developed in the 1950s as a malaria treatment, hydralazine showed antihypertensive ability and was soon repurposed.[A186841] Hydralazine is a hydrazine derivative vasodilator used alone or as adjunct therapy in the treatment of hypertension and only as adjunct therapy in the treatment of heart failure.[A186820,L8782,L8785] Hydralazine is no longer a first line therapy for these indications since the development of newer antihypertensive medications.[T691] Hydralazine hydrochloride was FDA approved on 15 January 1953.[L8779] |
Synonyms |
|
Brand Names |
|
Indication | Hydralazine is indicated alone or adjunct to standard therapy to treat essential hypertension.[L8782] A combination product with isosorbide dinitrate is indicated as an adjunct therapy in the treatment of heart failure.[L8785] |
Categories |
|
ATC-Code |
|
CAS number | 86-54-4 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Membrane primary amine oxidase | MNQKTILVLLILAVITIFALVCVLLVGRGGDGGEPSQLPHCPSVSPSAQP... | unknown | inhibitor |
Prolyl 4-hydroxylase subunit alpha-1 | MIWYILIIGILLPQSLAHPGFFTSIGQMTDLIHTEKDLVTSLKDYIKAEE... | unknown | inhibitor |
Hypoxia-inducible factor 1-alpha | MEGAGGANDKKKISSERRKEKSRDAARSRRSKESEVFYELAHQLPLPHNV... | unknown | inducer |
Cytochrome P450 3A4 | MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI... | unknown | inhibitor |
Serum albumin | MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA... | unknown | binder |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
CCDC/CSD | HYDLAZ01 |
PubChem | 5538708 |
PubChem | 3637 |
PubChem | 5538709 |
ChEBI | CHEBI:5775 |
ChEMBL | CHEMBL276832 |
Pharos | CHEMBL276832 |